Adrenal gland – Strong and diffuse PGP9.5 immunostaining in all tumor cells of a pheochromocytoma.

Breast – PGP9.5 negative breast cancer of no special type (NST).

Colon – PGP9.5 negative colorectal adenocarcinoma. A positive staining is seen in nerve fibres.

Esophagus – PGP9.5 negative adenocarcinoma.

Kidney – Chromophobe renal cell carcinoma showing variable intensity PGP9.5 staining in tumor cells (mosaic pattern).

Kidney – PGP9.5 negative clear cell carcinoma.

Larynx – Squamous cell carcinoma showing strong PGP9.5 positivity in tumor cells.

Liposarcoma with moderate intensity PGP9.5 immunostaining.

Liver – Cholangiocellular carcinoma showing PGP9.5 immunostaining of variable intensity in cancer cells (mosaic pattern).

Oral cavity – Squamous cell carcinoma showing strong PGP9.5 positivity in most tumor cells.

Ovary – Endometroid carcinoma with strong PGP9.5 staining in most tumor cells.

Ovary – Serous high-grade carcinoma showing variable intensity PGP9.5 staining in tumor cells (mosaic pattern).

Ovary – Serous high-grade carcinoma with moderate to strong PGP9.5 staining in tumor cells.

Pancreas – Neuroendocrine tumor with strong diffuse PGP9.5 immunostaining.

Pancreas – Neuroendocrine tumor with weak PGP9.5 immunostaining in only a few tumor cells.

Pleura – Malignant (epitheloid) mesothelioma with PGP9.5 immunostaining of variable intensity (mosaic pattern).

Pleura – Strong PGP9.5 immunostaining in a malignant (epitheloid) mesothelioma.

Prostate – PGP9.5 negative adenocarcinoma (Gleason 3+3=6).

Skin – Merkel cell carcinoma showing strong PGP9.5 immunostaining.

Stomach – PGP9.5 negative adenocarcinoma (intestinal type).

Testis – Embryonal carcinoma showing a moderate to strong PGP9.5 immunostaining in cancer cells.

Testis – Seminoma showing a strong PGP9.5 immunostaining in tumor cells.

Testis – Seminoma with variable intensity PGP9.5 staining in tumor cells (mosaic pattern).

Testis – Seminoma with weak to moderate PGP9.5 staining in tumor cells.

Thyroid – Anaplastic carcinoma with moderate to strong PGP9.5 positivity in tumor cells.

Thyroid – Medullary carcinoma showing strong PGP9.5 immunostaining.

Urinary bladder – Muscle-invasive urothelial carcinoma showing PGP9.5 immunostaining of variable intensity in cancer cells (mosaic pattern).